Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2

Conditions

Colorectal Neoplasms 46Squamous Cell Carcinoma of Head and Neck 23Carcinoma, Non-Small-Cell Lung 21Colonic Neoplasms 13Head and Neck Neoplasms 10Rectal Neoplasms 9Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 8Pancreatic Neoplasms 7Carcinoma, Squamous Cell 6Mouth Neoplasms 5Carcinoma 5Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Thyroid Neoplasms 3Solid Tumors 3Oropharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Pancreatic Ductal 3Breast Neoplasms 3Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Laryngeal Diseases 2Endometrial Neoplasms 2mCRC 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 4Cetuximab 3Bevacizumab 3pembrolizumab 2Pemetrexed 2Paclitaxel 2Oxaliplatin 2Leucovorin 2Fluorouracil 2Cisplatin 2Carboplatin 2Albumin-Bound Paclitaxel 2relacorilant 1Long Interspersed Nucleotide Elements 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Cetuximab × 90 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT06447662 2026-04-20

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Pfizer

Phase 1 Recruiting
330 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT06445062 2026-04-01

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Revolution Medicines, Inc.

Phase 1/2 Recruiting
1,130 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡